A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease

Nephron - Clinical Practice

Volumn 108, Issue 3, 2008, Pages

  Zeltner, Raoul ^a   Hilgers, Karl F ^a   Schmieder, Roland E ^a   Porst, Markus ^a   Schulze, Bernd D ^a   Hartner, Andrea ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Children and Youth Hospital   (Germany)

Author keywords

Alpha 8 integrin; Association study; Autosomal dominant polycystic kidney disease; End stage renal disease; Promoter

Indexed keywords

ALPHA 8 INTEGRIN; ALPHA INTEGRIN;

ADULT; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BODY SURFACE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; INTEGRINS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS (GENETICS); RISK ASSESSMENT; RISK FACTORS;

EID: 42549161556     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116887     Document Type: Article

References (42)

1. Giancotti FG: Complexity and specificity of integrin signalling. Nat Cell Biol 2000;2:E13-E14.
2. Giancotti FG, Ruoslahti E: Integrin signaling. Science 1999;285:1028-1032.
3. Kanahara K, Yorioka N, Arita M, Ohira N, Yamakido M: Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy. Nephron 1994;66:29-37.
4. Kuhara T, Kagami S, Kuroda Y: Expression of beta 1-integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 1997;8:1679-1687.
5. Jin DK, Fish AJ, Wayner EA, et al: Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol 1996;7:2636-2645.
6. Goligorsky MS, Lieberthal W, Racusen L, Simon EE: Integrin receptors in renal tubular epithelium: new insights into pathophysiology of acute renal failure. Am J Physiol 1993;264:F1-F8.
7. Kagami S, Border WA, Ruoslahti E, Noble NA: Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 1993;69:68-76.
8. Kagami S, Kondo S: Beta1-integrins and glomerular injury. J Med Invest 2004;51:1-13.
9. Kagami S, Urushihara M, Kondo S, et al: Effects of anti-alpha1 integrin subunit antibody on anti-Thy-1 glomerulonephritis. Lab Invest 2002;82:1219-1227.
10. Chen X, Moeckel G, Morrow JD, et al: Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004;165:617-630.
11. Varnum-Finney B, Venstrom K, et al: The integrin receptor alpha 8 beta 1 mediates interactions of embryonic chick motor and sensory neurons with tenascin-C. Neuron 1995;14:1213-1222.
12. Schnapp LM, Breuss JM, Ramos DM, Sheppard D, Pytela R: Sequence and tissue distribution of the human integrin alpha 8 subunit: a beta 1-associated alpha subunit expressed in smooth muscle cells. J Cell Sci 1995;108:537-544.
13. Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R: The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J Biol Chem 1995;270:23196-23202.
14. Denda S, Reichardt LF, Müller U: Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998;9:1425-1435.
15. Brandenberger R, Schmidt A, Linton J, et al: Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J Cell Biol 2001;154:447-458.
16. Hartner A, Schöcklmann H, Pröls F, Müller U, Sterzel RB: Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis. Kidney Int 1999;56:1468-1480.
17. Hartner A, Cordasic N, Klanke B, Müller U, Sterzel RB, Hilgers KF: The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 2002;160:861-867.
18. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF: Integrin alpha8 beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 1997;88:603-613.
19. Haas CS, Amann K, Schittny J, Blaser B, Muller U, Hartner A: Glomerular and renal vascular structural changes in alpha8 integrin-deficient mice. J Am Soc Nephrol 2003;14:2288-2296.
20. Wilson PD, Burrow CR: Cystic diseases of the kidney: Role of adhesion molecules in normal and abnormal tubulogenesis. Exp Nephrol 1999;7:114-124.
21. Daikha-Dahmane F, Narcy F, Dommergues M, Lacoste M, Beziau A, Gubler MC: Distribution of alpha-integrin subunits in fetal polycystic kidney diseases. Pediatr Nephrol 1997;11:267-273.
22. Battini L, Fedorova E, Macip S, Li X, Wilson PD, Gusella GL: Stable knockdown of polycystin-1 confers integrin-alpha2beta1-mediated anoikis resistance. J Am Soc Nephrol 2006;17:3049-3058.
23. Hartner A, Hilgers KF, Bitzer M, Veelken R, Schocklmann HO: Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis. J Mol Med 2003;81:32-42.
24. Riggs KJ, Merrell KT, Wilson G, Calame K: Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol 1991;11:1765-1769.
25. Joly D, Morel V, Hummel A, Ruello A, Nusbaum P, Patey N, et al: Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am J Pathol 2003;163:1791-1800.
26. Craig SW, Johnson RP: Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol 1996;8:74-85.
27. Lo SH, Yu QC, Degenstein L, Chen LB, Fuchs E: Progressive kidney degeneration in mice lacking tensin. J Cell Biol 1997;136:1349-1361.
28. Klingel R, Ramadori G, Schuppan D, Knittel T, Meyer zum Buschenfelde KH, Kohler H: Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease. Nephron 1993;65:111-118.
29. Daikha-Dahmane F, Dommergues M, Narcy F, Lacoste M, Gubler MC: Distribution and ontogenesis of tenascin in normal and cystic human fetal kidneys. Lab Invest 1995;73:547-557.
30. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 1995;5:1462-1468.
31. Ramasubbu K, Gretz N, Bachmann S: Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol 1998;9:937-945.
32. Bieritz B, Spessotto P, Colombatti A, Jahn A, Prols F, Hartner A: Role of alpha8 integrin in mesangial cell adhesion, migration, and proliferation. Kidney Int 2003;64:119-127.
33. Zargham R, Thibault G: Alpha 8 integrin expression is required for maintenance of the smooth muscle cell differentiated phenotype. Cardiovasc Res 2006;71:170-178.
34. Avner ED, Sweeney WE Jr, Nelson WJ: Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease. Proc Natl Acad Sci USA 1992;89:7447-7451.
35. Du J, Wilson PD: Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 1995;269:C487-C495.
36. Rocco MV, Neilson EG, Hoyer JR, Ziyadeh FN: Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease. Am J Physiol 1992;262:F679-F686.
37. Levine D, Rockey DC, Milner TA, Breuss JM, Fallon JT, Schnapp LM: Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol 2000;156:1927-1935.
38. Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault G: Alpha8beta1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium. J Mol Cell Cardiol 2004;36:343-353.
39. Lamnissou K, Zirogiannis P, Trygonis S, et al: Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genet Test 2004;8:319-324.
40. Persu A, Stoenoiu MS, Messiaen T, et al: Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002;11:229-241.
41. Ecder T, McFann KK, Raynolds MV, Schrier RW: No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol 2003;23:466-470.
42. Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O: Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2003;18:2032-203